Markowitz CE - Search Results

1

Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire.

Ma SL, Shea JA, Galetta SL, Jacobs DA, Markowitz CE, Maguire MG, Balcer LJ. Ma SL, et al. Among authors: markowitz ce. Am J Ophthalmol. 2002 May;133(5):686-92. doi: 10.1016/s0002-9394(02)01337-5. Am J Ophthalmol. 2002. PMID: 11992867

2

Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement: evidence for different clinical cohorts initial observations.

Gonen O, Moriarty DM, Li BS, Babb JS, He J, Listerud J, Jacobs D, Markowitz CE, Grossman RI. Gonen O, et al. Among authors: markowitz ce. Radiology. 2002 Oct;225(1):261-8. doi: 10.1148/radiol.2243011260. Radiology. 2002. PMID: 12355014

3

Immunomodulatory agents for the treatment of relapsing multiple sclerosis: a systematic review.

Galetta SL, Markowitz C, Lee AG. Galetta SL, et al. Arch Intern Med. 2002 Oct 28;162(19):2161-9. doi: 10.1001/archinte.162.19.2161. Arch Intern Med. 2002. PMID: 12390057

4

The "double panda sign" in Wilson's disease.

Jacobs DA, Markowitz CE, Liebeskind DS, Galetta SL. Jacobs DA, et al. Among authors: markowitz ce. Neurology. 2003 Oct 14;61(7):969. doi: 10.1212/01.wnl.0000085871.98174.4e. Neurology. 2003. PMID: 14557570 No abstract available.

5

Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite.

Balcer LJ, Baier ML, Cohen JA, Kooijmans MF, Sandrock AW, Nano-Schiavi ML, Pfohl DC, Mills M, Bowen J, Ford C, Heidenreich FR, Jacobs DA, Markowitz CE, Stuart WH, Ying GS, Galetta SL, Maguire MG, Cutter GR. Balcer LJ, et al. Among authors: markowitz ce. Neurology. 2003 Nov 25;61(10):1367-73. doi: 10.1212/01.wnl.0000094315.19931.90. Neurology. 2003. PMID: 14638957

6

Checkerboard fields in multiple sclerosis.

Tamhankar MA, Markowitz CE, Galetta SL. Tamhankar MA, et al. Among authors: markowitz ce. J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):268. doi: 10.1136/jnnp.2003.034371. J Neurol Neurosurg Psychiatry. 2005. PMID: 15654049 Free PMC article. No abstract available.

7

US FDA-approved disease-modifying treatments for multiple sclerosis: review of adverse effect profiles.

Galetta SL, Markowitz C. Galetta SL, et al. CNS Drugs. 2005;19(3):239-52. doi: 10.2165/00023210-200519030-00005. CNS Drugs. 2005. PMID: 15740178 Review.

8

Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.

Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, Baier ML, Frohman EM, Winslow H, Frohman TC, Calabresi PA, Maguire MG, Cutter GR, Balcer LJ. Fisher JB, et al. Among authors: markowitz ce. Ophthalmology. 2006 Feb;113(2):324-32. doi: 10.1016/j.ophtha.2005.10.040. Epub 2006 Jan 10. Ophthalmology. 2006. PMID: 16406539

9

Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25.

Raphael BA, Galetta KM, Jacobs DA, Markowitz CE, Liu GT, Nano-Schiavi ML, Galetta SL, Maguire MG, Mangione CM, Globe DR, Balcer LJ. Raphael BA, et al. Among authors: markowitz ce. Am J Ophthalmol. 2006 Dec;142(6):1026-35. doi: 10.1016/j.ajo.2006.06.060. Epub 2006 Oct 13. Am J Ophthalmol. 2006. PMID: 17046704

10

Treatment of Susac syndrome with gamma globulin and corticosteroids.

Fox RJ, Costello F, Judkins AR, Galetta SL, Maguire AM, Leonard B, Markowitz CE. Fox RJ, et al. Among authors: markowitz ce. J Neurol Sci. 2006 Dec 21;251(1-2):17-22. doi: 10.1016/j.jns.2006.08.007. Epub 2006 Oct 17. J Neurol Sci. 2006. PMID: 17052732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page